Macarena Peran
Overview
Explore the profile of Macarena Peran including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
58
Citations
629
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hernandez-Camarero P, Toledo B, Diaz-Ruano A, Gonzalez-Titos A, Garcia-Ortega M, Peran M
Int J Biol Sci
. 2025 Mar;
21(5):2155-2178.
PMID: 40083695
Endothelial-to-mesenchymal transition (EndMT) has gained increasing recognition as a crucial mechanism in the progression of solid cancers, influencing tumour heterogeneity, metastasis, and resistance to therapy. However, despite its growing importance,...
2.
Unveiling the microRNA landscape in pancreatic ductal adenocarcinoma patients and cancer cell models
Fenu G, Grinan-Lison C, Pisano A, Gonzalez-Titos A, Farace C, Fiorito G, et al.
BMC Cancer
. 2024 Oct;
24(1):1308.
PMID: 39448959
Background: Pancreatic ductal adenocarcinoma (PDAC) poses a significant challenge due to late-stage diagnoses resulting from nonspecific early symptoms and the absence of early diagnostic biomarkers. MicroRNAs (miRNAs) play a crucial...
3.
Lencioni G, Gregori A, Toledo B, Rebelo R, Immordino B, Amrutkar M, et al.
Semin Cancer Biol
. 2024 Sep;
106-107:217-233.
PMID: 39299411
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer with poor prognosis and rising global deaths. Late diagnosis, due to absent early symptoms and biomarkers, limits treatment mainly to chemotherapy, which...
4.
Toledo B, Zhu Chen L, Paniagua-Sancho M, Marchal J, Peran M, Giovannetti E
J Hematol Oncol
. 2024 Jun;
17(1):44.
PMID: 38863020
Macrophages infiltrating tumour tissues or residing in the microenvironment of solid tumours are known as tumour-associated macrophages (TAMs). These specialized immune cells play crucial roles in tumour growth, angiogenesis, immune...
5.
Abarca-Coloma L, Puga-Tejada M, Nunez-Quezada T, Gomez-Cruz O, Mawyin-Munoz C, Barungi S, et al.
Antibiotics (Basel)
. 2024 Mar;
13(3).
PMID: 38534648
Antibiotic overuse and the resulting antimicrobial resistance pose significant global public health challenges, providing an avenue for opportunistic pathogens like Acinetobacter baumannii to thrive. This study will report the trends...
6.
Toledo B, Deiana C, Sciano F, Brandi G, Marchal J, Peran M, et al.
Expert Rev Clin Pharmacol
. 2024 Feb;
17(4):323-347.
PMID: 38413373
Introduction: Treatment resistance poses a significant obstacle in oncology, especially in biliary tract cancer (BTC) and pancreatic cancer (PC). Current therapeutic options include chemotherapy, targeted therapy, and immunotherapy. Resistance to...
7.
Burke Z, Lyon C, Peran M
Front Cell Dev Biol
. 2023 Aug;
11:1260021.
PMID: 37601112
No abstract available.
8.
Garcia-Ortega M, Aparicio E, Grinan-Lison C, Jimenez G, Lopez-Ruiz E, Palacios J, et al.
Cancers (Basel)
. 2023 Jul;
15(14).
PMID: 37509327
Malignant melanoma (MM) can spread to other organs and is resistant in part due to the presence of cancer stem cell subpopulations (CSCs). While a controversial high dose of interferon-alpha...
9.
Barungi S, Hernandez-Camarero P, Moreno-Terribas G, Villalba-Montoro R, Marchal J, Lopez-Ruiz E, et al.
Front Cell Dev Biol
. 2023 Apr;
11:1148768.
PMID: 37009489
Cardiovascular diseases (CVD) are the leading causes of death and disability in the world. Among all CVD, the most common is coronary artery disease (CAD). CAD results from the complications...
10.
Toledo B, Gonzalez-Titos A, Hernandez-Camarero P, Peran M
Int J Mol Sci
. 2023 Mar;
24(5).
PMID: 36901917
The acquisition of resistance to traditional chemotherapy and the chemoresistant metastatic relapse of minimal residual disease both play a key role in the treatment failure and poor prognosis of cancer....